Clinical Trial Update: CAR-T Immunotherapy Targeting CD19- ALL [Phase 1, Phase 2]

View source ↗

Summary

This document updates a Phase 1/Phase 2 clinical trial of a CD19-targeted CAR-T cell therapy for B-cell acute lymphoblastic leukemia, sponsored by Shenzhen Geno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: B-cell Leukemia | Phase 1, Phase 2 | Status: RECRUITING